The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Oceania Healthcare’s (OCA) Chief Executive, Earl Gasparich, has resigned from his role with the company
  • Earl held the position for seven years, during which time he oversaw the company’s listing on the ASX
  • Gasparich will succeed Glen Sowry as CEO of Metlifecare, following an announcement from the company today   
  • The Oceania Board has appointed Chief Financial Officer Brent Pattison as Acting Chief Executive Officer, effective immediately
  • Oceania is down 2.26 per cent, trading at $1.30

Oceania Healthcare’s (OCA) Chief Executive, Earl Gasparich, has resigned from his role with the company.

Oceania Healthcare is a leading provider of healthcare services in New Zealand.

The outgoing CEO first joined Oceania in August 2014 and led the company through a period of growth and transformation, including its initial public offering in May 2017 and the challenges of COVID-19.

Outside of his work at Oceania Healthcare, Gasparich also volunteers on the Boards of a number of charities involved in the provision of community services.

The Oceania Board has appointed Brent Pattison, Oceania Healthcare Chief Financial Officer, to the role of Acting Chief Executive Officer, effective immediately.

“The Board extend our gratitude and thanks to Earl for his contribution over his six and a half years with us,” said Oceania Chair Liz Coutts.

The company says they are now well positioned for growth in the years ahead.

Earl Gasparich will go on to succeed Glen Sowry as CEO of New Zealand-based retirement village provider Metlifecare.

“Earl knows the sector well and we are highly confident that he brings the skill and experience needed to deliver the ongoing leadership and capability to progress Metlifecare’s growth strategy,” said Metlifecare Chair, Paul McClintock.

Sowry will leave Metlifecare on March 31, and Gasparich is expected to commence at Metlifecare in the middle of the year.

Oceania is down 2.26 per cent, trading at $1.30 at 4:00 pm AEDT.

OCA by the numbers
More From The Market Online
Disability NDIS concept

Freedom Care Group reveals NDIS wants to ban it providing program services

Shares in Freedom Care Group (ASX:FCG) were down more than -3% on Wednesday after revealing the…
Image representing bacterial infections in the immune system

Recce reaches key dosing milestone in testing of skin infection gel

Recce Pharmaceuticals Ltd has successfully dosed 20 out of 30 participants in its Phase II trial…
Bank of England London town

Wellnex bumps first $3M payment for Pain Away into 1Q25 – when it lists in London

Wellnex Life Ltd (ASX:WNX) has unveiled its plans to defer a $2.95M payment to 360 Health…
DNA RNA therapy concept

PYC Therapeutics moves into final stage of child blindness study

PYC has been approved to escalate doses of its drug candidate VP-001, treating Retinitis Pigmentosa 11,…